The Prognostic Value of Biomarkers in Non-ST-Elevation Acute Coronary Syndrome Patients that are Treated by an Early Invasive Strategy: Insights from the OPTIMA-2 Trial

Autor: Nick D. Fagel, Maarten A. Vink, Antonius A.C.M. Heestermans, Robert K. Riezebos

Publikováno v: Reviews in Cardiovascular Medicine, Vol 24, Iss 4, p 117 (2023)

Background: Patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) consists of a heterogenic population and improvement in identification of a specific risk profile is needed. In this study we aimed to obtain better insight in the role of

Externí odkaz: https://doaj.org/article/6b9ed05d6ec64790a7204b9dff2be647

The Prognostic Value of Biomarkers in Non-ST-Elevation Acute Coronary Syndrome Patients that are Treated by an Early Invasive Strategy: Insights from the OPTIMA-2 Trial

Autor: Robert K. Riezebos, Antonius A.C.M. Heestermans, Maarten A. Vink, Nick D. Fagel

Publikováno v: Reviews in Cardiovascular Medicine. 24:117

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::172bd6b21ef299edabfecd421ab09c89
https://doi.org/10.31083/j.rcm2404117

The Effect of the Timing of Invasive Management on Cardiac Function in Patients with NSTE-ACS, Insights from the OPTIMA-2 Randomized Controlled Trial

Autor: Stefan G. J. Leuven, Michelle M. de Leau, Nick D. Fagel, Wouter J. Kikkert, Loek van Heerebeek, Robert K. Riezebos

Publikováno v: Journal of Clinical Medicine
Volume 10
Issue 16
Journal of clinical medicine, 10(16):3636. Multidisciplinary Digital Publishing Institute (MDPI)
Journal of Clinical Medicine, Vol 10, Iss 3636, p 3636 (2021)

The timing of coronary angiography in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) remains a matter of debate. The relationship between the timing of invasive management and left ventricular function (LVF) is largely unknown. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85d678ecb42373eb52a8a363332f973f

Five-year results of the complete versus culprit vessel percutaneous coronary intervention in multivessel disease using drug-eluting stents II (CORRECT II) study: a prospective, randomised controlled trial

Autor: Giovanni Amoroso, M. Maarse, Ton Slagboom, Mark S. Patterson, Nick D. Fagel, M. J. Suttorp, J. P. Herrman, F. C. van Nooijen, GertJan Laarman, R J van der Schaaf, Maarten A. Vink

Publikováno v: Netherlands heart journal, 27(6), 310-320. Bohn Stafleu van Loghum
Netherlands Heart Journal

Objectives/background: In patients with multivessel coronary artery disease (MVD) the decision whether to treat a single culprit vessel or to perform multivessel revascularisation may be challenging. The purpose of this study was to evaluate the long

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c667004dcabd52109e554fdf0c5c0739
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85066114135&origin=inward

TCT-498 Final Results of the Optimal Timing of Coronary Intervention in Unstable Angina-2 (OPTIMA-2) trial

Autor: Robert K. Riezebos, Giovanni Amoroso, Ton Slagboom, Maarten A. Vink, Freek W.A. Verheugt, René J. van der Schaaf, Nick D. Fagel, Jean-Paul R. Herrman

Publikováno v: Journal of the American College of Cardiology. 74:B493

In non–ST-segment elevated acute coronary syndrome (NSTE-ACS), a routine invasive approach is advocated among intermediate- or high-risk patients. It was hypothesized that modern antiplatelet therapy including ticagrelor would safely allow direct i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::402c4c00718c50285577416339a540c0
https://doi.org/10.1016/j.jacc.2019.08.595